(
A) Kaplan-Meier survival analysis across CMS groups for overall survival (see Materials and methods section for clinical data extracted from TCGA data portal). (
B) CNA profile bar plot with CNA alterations frequencies of 462 colon adenocarcinoma (TCGA-COAD cohort) and 164 rectum adenocarcinoma (TCGA-READ) samples using CNApp default thresholds (read for gains and blue for losses). (
C) Box plot showing the distribution of FCS according to the CMS groups for 309 colon adenocarcinoma samples (
Figure 4—figure supplement 1—source data 1). Wilcoxon rank-sum test was performed for each pair of groups to assess significant differences. Significance is expressed as: p-value≤0.001 (***); p -value ≤ 0.01 (**); p -value ≤ 0.05 (*); p -value > 0.05 (ns). (
D) BCS values density plot for MSI (brown) and MSS (green) sample groups after
Classifier model section implementation selecting BCS as classifier variable (
N = 297 colon cancer samples). Vertical blue line at BCS = 4.75, as interception value between groups. (
E) Sensitivity and specificity curves in ROC analysis across BCS threshold values showing the intersection value of 3.75 (green vertical line). The blue line shows our proposed threshold of BCS = 4. (
F) Distribution of chromosome arm 20q copy-number amplitude values according to the CMS groups. Wilcoxon rank-sum test was performed for each pair of groups to assess significant differences. Significance is shown as p-value≤0.001 (***); p-value≤0.01 (**); p-value≤0.05 (*); p-value>0.05 (ns). (TIFF 664 KB).